Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Taspoglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist which demonstrated meaningful anti-hyperglycaemic and weight loss effects in type 2 diabetic patients. The present study evaluated single dose pharmacokinetics and tolerability of taspoglutide in subjects with varying degrees of renal impairment and matched healthy subjects.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
